67 companies

Mereo BioPharma Group

Market Cap: US$276.8m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

MREO

US$1.68

7D

10.5%

1Y

-62.4%

Palantir Technologies

Market Cap: US$420.3b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$174.03

7D

-4.7%

1Y

435.5%

RenovoRx

Market Cap: US$35.0m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$0.94

7D

-15.7%

1Y

-11.3%

Aldeyra Therapeutics

Market Cap: US$322.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$5.44

7D

3.6%

1Y

0.9%

OS Therapies

Market Cap: US$68.9m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$2.18

7D

30.5%

1Y

-45.4%

Vanda Pharmaceuticals

Market Cap: US$257.6m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.56

7D

8.8%

1Y

-14.8%

Circle Internet Group

Market Cap: US$34.5b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

CRCL

US$141.58

7D

-12.2%

1Y

n/a

ACADIA Pharmaceuticals

Market Cap: US$4.3b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$25.06

7D

1.0%

1Y

59.0%

Workday

Market Cap: US$60.3b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$231.85

7D

8.5%

1Y

-0.3%

Gorilla Technology Group

Market Cap: US$500.8m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

GRRR

US$17.97

7D

6.8%

1Y

642.6%

ADMA Biologics

Market Cap: US$4.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$17.63

7D

7.6%

1Y

-3.2%

Cellebrite DI

Market Cap: US$3.8b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

CLBT

US$16.16

7D

19.5%

1Y

-1.3%

HubSpot

Market Cap: US$23.2b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

HUBS

US$448.20

7D

6.5%

1Y

-9.9%

aTyr Pharma

Market Cap: US$480.1m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

New

ATYR

US$4.91

7D

-12.5%

1Y

159.8%

Sea

Market Cap: US$105.0b

Through its subsidiaries, operates as a consumer internet company in Southeast Asia, Latin America, the rest of Asia, and internationally.

SE

US$177.27

7D

21.2%

1Y

115.6%

Atlassian

Market Cap: US$43.8b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

TEAM

US$169.17

7D

6.2%

1Y

6.4%

Zeta Global Holdings

Market Cap: US$4.6b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

ZETA

US$19.71

7D

9.4%

1Y

-18.7%

Reddit

Market Cap: US$46.1b

Operates a digital community in the United States and internationally.

RDDT

US$241.76

7D

9.5%

1Y

344.7%

Commvault Systems

Market Cap: US$8.0b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

CVLT

US$179.78

7D

-3.2%

1Y

19.8%

Krystal Biotech

Market Cap: US$4.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

KRYS

US$146.30

7D

6.4%

1Y

-26.4%

Anavex Life Sciences

Market Cap: US$854.2m

Operates as a biopharmaceutical company.

AVXL

US$9.59

7D

-15.5%

1Y

52.7%

Protalix BioTherapeutics

Market Cap: US$118.0m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

PLX

US$1.54

7D

-4.3%

1Y

60.4%

Glimpse Group

Market Cap: US$28.0m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

VRAR

US$1.42

7D

13.6%

1Y

47.9%

MNTN

Market Cap: US$1.6b

Operates a technology platform that brings performance marketing to Connected TV.

MNTN

US$22.85

7D

1.0%

1Y

n/a

Evaxion

Market Cap: US$18.2m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

EVAX

US$3.22

7D

16.2%

1Y

-81.0%

Creative Medical Technology Holdings

Market Cap: US$8.1m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

CELZ

US$3.29

7D

12.8%

1Y

1.7%

Trade Desk

Market Cap: US$25.5b

Operates as a technology company in the United States and internationally.

TTD

US$54.95

7D

3.3%

1Y

-46.5%

Aprea Therapeutics

Market Cap: US$9.8m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

APRE

US$1.65

7D

-2.4%

1Y

-56.4%

Prothena

Market Cap: US$444.1m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

PRTA

US$8.53

7D

11.2%

1Y

-59.7%

Arcturus Therapeutics Holdings

Market Cap: US$529.0m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ARCT

US$17.91

7D

57.2%

1Y

-16.4%

Protagonist Therapeutics

Market Cap: US$3.5b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$56.21

7D

4.6%

1Y

34.2%

Pure Storage

Market Cap: US$19.2b

Engages in the provision of data storage and management technologies, products, and services in the United States and internationally.

PSTG

US$58.48

7D

2.0%

1Y

-5.6%

VTEX

Market Cap: US$744.2m

Provides software-as-a-service digital commerce platform for enterprise brands and retailers.

VTEX

US$4.05

7D

-3.3%

1Y

-46.8%

KVH Industries

Market Cap: US$104.9m

Engages in the design, development, manufacture, and marketing of mobile connectivity solutions for the marine and land mobile markets in the United States and internationally.

New

KVHI

US$5.44

7D

4.2%

1Y

22.2%

Roku

Market Cap: US$13.3b

Operates a TV streaming platform in the United States and internationally.

ROKU

US$92.33

7D

12.6%

1Y

49.0%

Exelixis

Market Cap: US$10.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$37.76

7D

0.9%

1Y

42.0%

Page 1 of 2